News ASKP3 Patient Portal to offer accurate fact-based info on ketamine Platform is intended to educate patients and medical providers on benefits of ketamine for treating pain and mood disorders Rowan DunneOctober 14, 2022
Canada Vancouver mushroom dispensaries continue to operate in legal grey area These relatively new stores remind people about the final days of the cannabis prohibition era in Canada Rowan DunneOctober 3, 2022
Canada Numinus launches ketamine-assisted therapy in Toronto Neurology Centre of Toronto in Forest Hill expands its therapy catalogue Rowan DunneSeptember 21, 2022
Psychedelics MindMed doses first patient with MDMA-like compounds in new trial New study will compare the effects of MDA and MDMA in humans for the first time Rowan DunneSeptember 20, 2022
Canada ATMA receives Health Canada approval for new psilocybin trial Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic Rowan DunneSeptember 15, 2022
Stock News MindMed re-establishes Nasdaq listing requirements News follows a 1-for-15 reverse share split by the company at the end of August and ensuing loss of stock value Rowan DunneSeptember 14, 2022
Cannabis Delix gets recognized as leading start-up by Nature Biotechnology Renowned academic journal praises company for development of psychoplastogens Rowan DunneSeptember 14, 2022
Canada DOSED 2 screening sells out at Vancouver’s Rio Theatre Film screening was followed by audience Q&A session hosted by director Rowan DunneSeptember 13, 2022
Canada Algernon receives approval to conduct DMT study in the Netherlands New clinical research will assess efficacy of IV formulation for the treatment of strokes Rowan DunneSeptember 12, 2022
Canada Optimi makes history with gargantuan psilocybin harvest Company believes it has completed the largest mushroom harvest Canada has ever seen Rowan DunneSeptember 9, 2022